Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

IDEXX LABORATORIES INC /DE (IDXX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

IDEXX LABORATORIES INC /DE (IDXX), most recent 12 months reported: revenue $4.55B, net income $1.14B, free cash flow $1.25B. Latest balance sheet on file: liquid cash $196.93M, total debt $968.86M, net cash -$771.93M. From SEC filings. More on IDEXX LABORATORIES INC /DE: Revenue · Profitability · Cash flow · Debt Others in In Vitro & In Vivo Diagnostic Substances: QUIDELORTHO CORP · Lantheus Holdings, Inc. · Neogen Corporation · MYRIAD GENETICS, INC. · INTELLIA THERAPEUTICS, INC. · Alpha Teknova, Inc. · ImmuCell Corporation · Anbio Biotechnology

Stock screener

Watchlist